Biossci

Biossci is a Wuhan-based life science research services company that operates as a CRO focused on pathology and related preclinical laboratory services. The company provides integrated experimental support spanning pathology, molecular biology, protein immunology, cell biology, bioanalysis, and animal-model pathology evaluation, and also sells research reagents, consumables, and instruments. Public descriptions emphasize its role as a service provider for medical researchers and pharmaceutical R&D companies rather than as a developer of a disclosed therapeutic pipeline. Biossci appears to have built a multi-city service network in China and promotes a central laboratory of about 4,000 square meters with broad technical capabilities. The company has also announced expansion into clinical development-related collaboration around depression diagnostics and nanobody drug technologies, but no named internal drug candidates are publicly detailed.